In myeloma cells that do not express ALK1, BMP9 is dependent on ALK2 for signaling as shown using CRISPR/Cas9 to knock out ALK2 in INA-6 cells (Supplementary Fig. 2). The gene discussed is ACVR1; the disease is plasma cell myeloma.